Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010136
Filing Date
2025-03-13
Accepted
2025-03-13 07:30:40
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1779208
2 ex19-1.htm EX-19.1 99200
3 ex23-1.htm EX-23.1 7268
4 ex31-1.htm EX-31.1 17411
5 ex31-2.htm EX-31.2 17393
6 ex32-1.htm EX-32.1 7417
7 ex32-2.htm EX-32.2 7259
8 form10-k_0001.jpg GRAPHIC 29307
9 form10-k_0002.jpg GRAPHIC 25784
10 form10-k_0003.jpg GRAPHIC 47514
11 form10-k_0004.jpg GRAPHIC 21559
12 form10-k_0005.jpg GRAPHIC 25102
13 fin_001.jpg GRAPHIC 25771
14 form10-k_007.jpg GRAPHIC 164995
15 form10-k_006.jpg GRAPHIC 104913
16 ex23-1_001.jpg GRAPHIC 5212
17 ex23-1_002.jpg GRAPHIC 6512
  Complete submission text file 0001493152-25-010136.txt   6667812

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE indp-20241231.xsd EX-101.SCH 32350
19 XBRL CALCULATION FILE indp-20241231_cal.xml EX-101.CAL 49685
20 XBRL DEFINITION FILE indp-20241231_def.xml EX-101.DEF 107463
21 XBRL LABEL FILE indp-20241231_lab.xml EX-101.LAB 350841
22 XBRL PRESENTATION FILE indp-20241231_pre.xml EX-101.PRE 268709
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 489438
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40652 | Film No.: 25733840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)